# Effects of Baclofen on Presynaptic Inhibition in Humans

> **NCT04471714** · PHASE2 · WITHDRAWN · sponsor: **University of Alberta**

## Conditions studied

- Spasticity, Muscle
- Spinal Cord Injuries

## Interventions

- **DRUG:** Baclofen

## Key facts

- **NCT ID:** NCT04471714
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-01-10
- **Primary completion:** 2022-03-17
- **Final completion:** 2022-03-17
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study recruitment was halted due to restrictions and we have decided to not pursue it further.
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04471714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04471714, "Effects of Baclofen on Presynaptic Inhibition in Humans". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04471714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*